Xiaoyan Ke

6.5k total citations · 2 hit papers
189 papers, 3.4k citations indexed

About

Xiaoyan Ke is a scholar working on Cognitive Neuroscience, Molecular Biology and Oncology. According to data from OpenAlex, Xiaoyan Ke has authored 189 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Cognitive Neuroscience, 46 papers in Molecular Biology and 39 papers in Oncology. Recurrent topics in Xiaoyan Ke's work include Autism Spectrum Disorder Research (48 papers), Lymphoma Diagnosis and Treatment (37 papers) and Acute Myeloid Leukemia Research (24 papers). Xiaoyan Ke is often cited by papers focused on Autism Spectrum Disorder Research (48 papers), Lymphoma Diagnosis and Treatment (37 papers) and Acute Myeloid Leukemia Research (24 papers). Xiaoyan Ke collaborates with scholars based in China, United States and Netherlands. Xiaoyan Ke's co-authors include Zuhong Lu, Kangkang Chu, Xinyin Chen, Lin Fu, Hirokazu Yoshikawa, Niobe Way, Yi Zheng, Diane Hughes, Guangming Ling and Yueming Jia and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Xiaoyan Ke

175 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of mental disorders in school children and adolescents in China: diagnostic data from detailed clinical assessments of 17,524 individuals

2021 239 citations Fenghua Li, Yonghua Cui et al. Journal of Child Psychology and Psychiatry profile →
Signalling pathways in autism spectrum disorder: mechanisms and therapeutic implications

2022 133 citations Xiaoyan Ke et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoyan Ke China	29	1.1k	915	496	463	445	189	3.4k
Young Hoon Sung South Korea	30	488 0.5×	1.5k 1.7×	260 0.5×	248 0.5×	360 0.8×	102	3.8k
Shirley Xin Li Hong Kong	43	1.8k 1.7×	1.4k 1.6×	488 1.0×	274 0.6×	476 1.1×	178	5.6k
Toyojiro Matsuishi Japan	42	790 0.7×	2.1k 2.3×	494 1.0×	229 0.5×	793 1.8×	262	7.1k
Punit Shah United Kingdom	37	1.4k 1.4×	1.7k 1.8×	724 1.5×	257 0.6×	156 0.4×	125	4.4k
Teresa Bennett Canada	32	1.3k 1.2×	542 0.6×	1.0k 2.1×	148 0.3×	374 0.8×	91	2.8k
Susan L. Connors United States	26	725 0.7×	1.1k 1.2×	239 0.5×	183 0.4×	411 0.9×	37	2.7k
Roberto Giorda Italy	41	552 0.5×	2.0k 2.1×	487 1.0×	668 1.4×	2.0k 4.4×	157	5.1k
Chiara Maria Mazzanti Italy	38	1.2k 1.2×	2.1k 2.3×	626 1.3×	349 0.8×	1.0k 2.4×	159	6.9k
Tom Smeets Netherlands	58	2.0k 1.9×	1.1k 1.3×	1.1k 2.2×	1.9k 4.0×	200 0.4×	204	9.8k
Idan Menashe Israel	25	745 0.7×	747 0.8×	207 0.4×	121 0.3×	749 1.7×	88	2.5k

Countries citing papers authored by Xiaoyan Ke

Since Specialization

Citations

This map shows the geographic impact of Xiaoyan Ke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyan Ke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyan Ke more than expected).

Fields of papers citing papers by Xiaoyan Ke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyan Ke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyan Ke. The network helps show where Xiaoyan Ke may publish in the future.

Co-authorship network of co-authors of Xiaoyan Ke

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyan Ke. A scholar is included among the top collaborators of Xiaoyan Ke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyan Ke. Xiaoyan Ke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Ning, et al.. (2025). Pragmatic performance, its relationship with symptom severity, and early clinical predictors of pragmatics in 5 ~ 6-year-old children with autism spectrum disorder. BMC Psychiatry. 25(1). 58–58. 1 indexed citations

Xue, Fei, Rui Liu, Fan Yang, et al.. (2025). Sequential CD19-20 CAR T-cell therapy for refractory/relapsed diffuse large B-cell lymphoma. Cytotherapy. 27(8). 910–916.

Dou, Yimeng, Rui Liu, Fan Yang, et al.. (2025). Efficacy and Safety of CART Cell Therapy in Aggressive B‐Cell Lymphomas Involving the Gastrointestinal Tract. Cancer Reports. 8(1). e70083–e70083.

Bao, Li, et al.. (2023). Efficacy and Safety of Zanubrutinib-Containing Regimens in Patients with Secondary CNS Relapse in Diffuse Large B-Cell Lymphoma. Blood. 142(Supplement 1). 6095–6095.

Han, Lu, Yuanbo Li, Zhen Chen, et al.. (2023). Phospholipase A2-activating protein induces mitophagy through anti-apoptotic MCL1-mediated NLRX1 oligomerization. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1870(6). 119487–119487. 5 indexed citations

Hu, Kai, Xiaoyan Ke, Hui Shi, et al.. (2023). PB2326: OUTCOMES OF ANTI-CANCER THERAPY IN PATIENTS WITH PROGRESSIVE REFRACTORY/RELAPSED B-CELL LYMPHOMA DURING SEVERE CORONAVIRUS DISEASE 2019 (COVID-19): A REAL-WORLD STUDY FROM CHINA. HemaSphere. 7(S3). e4592720–e4592720. 1 indexed citations

Yang, Ting, Li Chen, Ying Dai, et al.. (2022). Vitamin A Status Is More Commonly Associated With Symptoms and Neurodevelopment in Boys With Autism Spectrum Disorders—A Multicenter Study in China. Frontiers in Nutrition. 9. 851980–851980. 18 indexed citations

Yang, Ting, Jie Chen, Ying Dai, et al.. (2022). Vitamin D status is primarily associated with core symptoms in children with autism spectrum disorder: A multicenter study in China. Psychiatry Research. 317. 114807–114807. 9 indexed citations

Yang, Ting, Jie Chen, Ying Dai, et al.. (2022). A Multi-Center Study on the Relationship Between Developmental Regression and Disease Severity in Children With Autism Spectrum Disorders. Frontiers in Psychiatry. 13. 796554–796554. 8 indexed citations

10.

Li, Fenghua, Yonghua Cui, Ying Li, et al.. (2021). Prevalence of mental disorders in school children and adolescents in China: diagnostic data from detailed clinical assessments of 17,524 individuals. Journal of Child Psychology and Psychiatry. 63(1). 34–46. 239 indexed citations breakdown →

11.

Li, Yun, et al.. (2021). Shared and Distinct Topologically Structural Connectivity Patterns in Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Frontiers in Neuroscience. 15. 664363–664363. 14 indexed citations

12.

Chen, Yu, Hui Fang, Chunyan Li, et al.. (2020). Gut Bacteria Shared by Children and Their Mothers Associate with Developmental Level and Social Deficits in Autism Spectrum Disorder. mSphere. 5(6). 23 indexed citations

13.

Tang, Chuangao, Wenming Zheng, Yuan Zong, et al.. (2020). Automatic Identification of High-Risk Autism Spectrum Disorder: A Feasibility Study Using Video and Audio Data Under the Still-Face Paradigm. IEEE Transactions on Neural Systems and Rehabilitation Engineering. 28(11). 2401–2410. 25 indexed citations

14.

Cheng, Zhiheng, Lei Zhou, Kai Hu, et al.. (2018). Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 53(9). 1089–1095. 9 indexed citations

15.

Cao, Yuan, et al.. (2016). Reliability and validity of the Chinese version of the Griffith empathy measure parent ratings. Zhonghua xingwei yixue yu naokexue zazhi. 25(6). 561–564. 4 indexed citations

16.

Wang, Yanfang, Hua Wang, Yan Liu, et al.. (2015). [Detection of Molecular Cytogenetic Aberrations by Fluorescence in Situ Hybridization in Different Bone Marrow Samples of Multiple Myeloma].. PubMed. 23(5). 1352–6. 2 indexed citations

17.

Chang, Lung‐Ji, Lujia Dong, Jun Zhu, et al.. (2015). 4SCAR19 Chimeric Antigen Receptor-Modified T Cells As a Breakthrough Therapy for Highly Chemotherapy-Resistant Late-Stage B Cell Lymphoma Patients with Bulky Tumor Mass. Blood. 126(23). 264–264. 8 indexed citations

18.

Dong, Fei, et al.. (2013). Clinical analysis of chemotheray-induced lung injury in 26 patients with malignant hematological diseases. 22(2). 94–97.

19.

Jin, Hua, et al.. (2007). Reliability and validity of the developmental coordination disorder questionnaire. Zhonghua xingwei yixue yu naokexue zazhi. 16(9). 852–853. 1 indexed citations

20.

Gao, Zifen, et al.. (2005). [Factors affecting the prognosis of diffuse large B-cell lymphoma in Chinese].. PubMed. 44(9). 681–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact